K-numberK241567
Device nameMC2 Portable X-ray System
ApplicantOxos Medical
Product codeOWB
Device classClass II
Decision dateDec 6, 2024
DecisionSubstantially Equivalent
Regulation892.1650
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The MC2 Portable X-ray System is a handheld, battery-powered X-ray device designed for point-of-care radiographic imaging of extremities distal to the shoulders and knees in adult patients. It consists of an emitter and cassette that interface wirelessly with a tablet or monitor via the OXOS Device App, and supports three imaging modes: single radiography, serial radiography, and fluoroscopy. The device includes safety features such as LIDAR-based source-to-skin distance monitoring and infrared tracking for proper alignment.

Technological characteristics

The MC2 uses an iRay Mercu0909X detector (9×9 inches, 5 fps) versus the predicate's 12×12 inch detector at 20 fps; both employ cesium iodide scintillators and LIDAR for source-to-skin distance control. The MC2 has a slightly higher resolution pixel pitch (139 μm vs. 145 μm), larger focal spot (0.8 vs. 0.6), and longer exposure times (40–200 ms vs. 10 ms). MTF and DQE values are similar between devices. Both support single and fluoroscopic imaging modes with comparable kVp ranges (40–80 kVp for MC2 vs. 30–80 kVp for predicate).

Test standards cited

Compliance demonstrated with IEC 60601-1 (general safety), IEC 60601-1-3 (radiation protection), IEC 60601-2-54 (radiography and radioscopy), IEC 60601-2-43 (interventional procedures), IEC 60601-2-28 (X-ray tube assemblies), IEC 62304 (software lifecycle), ISO 14971 (risk management), and 21 CFR 1020.30–1020.32 (diagnostic X-ray system requirements). DICOM 3.0 compliance and cybersecurity threat modeling per FDA guidance were also verified.

Substantial equivalence argument

The MC2 shares core technological principles and design features with the predicate Virtual C DRF, including fluoroscopic and radiographic imaging modes, identical scintillator material, identical LIDAR-based source-to-skin distance control, and similar MTF/DQE performance. Although the MC2 has a smaller detector and narrower anatomical scope (extremities only, not surgery), these differences do not raise new safety or effectiveness concerns; comprehensive bench testing and a clinical image quality study involving five radiologists confirmed adequate imaging performance for the stated orthopedic indications. The safety interlocks, electrical standards compliance, and software controls are equivalent or exceed the predicate device.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →